Joe E. Kiani Sells 104,870 Shares of Masimo Corp. (MASI) Stock
Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 104,870 shares of the business’s stock in a transaction that occurred on Tuesday, November 29th. The stock was sold at an average price of $62.27, for a total value of $6,530,254.90. Following the completion of the sale, the chief executive officer now owns 119,241 shares of the company’s stock, valued at $7,425,137.07. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Masimo Corp. (NASDAQ:MASI) traded up 0.60% during mid-day trading on Tuesday, hitting $62.14. The stock had a trading volume of 297,312 shares. Masimo Corp. has a one year low of $33.03 and a one year high of $62.62. The stock’s 50 day moving average price is $59.35 and its 200 day moving average price is $55.78. The firm has a market capitalization of $3.09 billion, a price-to-earnings ratio of 30.00 and a beta of 0.98.
Masimo Corp. (NASDAQ:MASI) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $0.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.10. The business earned $167.60 million during the quarter, compared to the consensus estimate of $165.51 million. Masimo Corp. had a return on equity of 29.42% and a net margin of 16.31%. Masimo Corp.’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period last year, the company earned $0.36 earnings per share. Analysts forecast that Masimo Corp. will post $2.14 EPS for the current year.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Acadian Asset Management LLC boosted its position in shares of Masimo Corp. by 633.2% in the third quarter. Acadian Asset Management LLC now owns 900,553 shares of the company’s stock valued at $53,573,000 after buying an additional 777,735 shares during the period. First Republic Investment Management Inc. bought a new position in shares of Masimo Corp. during the first quarter valued at approximately $12,638,000. Henderson Group PLC boosted its position in shares of Masimo Corp. by 57.6% in the second quarter. Henderson Group PLC now owns 725,066 shares of the company’s stock valued at $38,077,000 after buying an additional 265,011 shares during the period. Matarin Capital Management LLC bought a new position in shares of Masimo Corp. during the third quarter valued at approximately $14,716,000. Finally, BlackRock Advisors LLC boosted its position in shares of Masimo Corp. by 49.7% in the second quarter. BlackRock Advisors LLC now owns 741,931 shares of the company’s stock valued at $38,962,000 after buying an additional 246,358 shares during the period. 82.49% of the stock is owned by hedge funds and other institutional investors.
Several brokerages have commented on MASI. Wedbush reaffirmed an “outperform” rating and issued a $75.00 price target on shares of Masimo Corp. in a research report on Monday, November 14th. BTIG Research reaffirmed a “hold” rating on shares of Masimo Corp. in a research report on Friday, August 5th. Zacks Investment Research downgraded Masimo Corp. from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 4th. Finally, Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $55.00 price target (up from $52.00) on shares of Masimo Corp. in a research report on Friday, August 5th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Masimo Corp. presently has an average rating of “Buy” and an average price target of $55.00.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.